These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14214646)

  • 21. The therapy of maple syrup urine disease.
    Snyderman SE
    Am J Dis Child; 1967 Jan; 113(1):68-73. PubMed ID: 6015908
    [No Abstract]   [Full Text] [Related]  

  • 22. Leucine equivalency system in managing branched chain ketoaciduria.
    Smith BA; Waisman HA
    J Am Diet Assoc; 1971 Oct; 59(4):342-6. PubMed ID: 5095277
    [No Abstract]   [Full Text] [Related]  

  • 23. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease].
    Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THE DIAGNOSIS OF MAPLE SYRUP URINE DISEASE (BRANCHED- CHAIN KETOACIDURIA) BY THE IN VITRO STUDY OF THE PERIPHERAL LEUKOCYTE.
    DANCIS J; HUTZLER J; LEVITZ M
    Pediatrics; 1963 Aug; 32():234-8. PubMed ID: 14044451
    [No Abstract]   [Full Text] [Related]  

  • 25. Maple syrup urine disease; an inborn error of the metabolism of valine, leucine, and isoleucine associated with gross mental deficiency.
    MACKENZIE DY; WOOLF LI
    Br Med J; 1959 Jan; 1(5114):90-1. PubMed ID: 13608087
    [No Abstract]   [Full Text] [Related]  

  • 26. M aple syrup urine disease. A review with a report of an additional case.
    Schwartz JF; Kolendrianos ET
    Dev Med Child Neurol; 1969 Aug; 11(4):460-70. PubMed ID: 5805351
    [No Abstract]   [Full Text] [Related]  

  • 27. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease.
    Kindt E; Halvorsen S
    Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of maple syrup urine disease by determination of L-valine, L-isoleucine, L-leucine and L-phenylalanine in neonatal blood spots by gas chromatography-mass spectrometry.
    Deng C; Deng Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):261-8. PubMed ID: 12860033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maple syrup urine disease variant: report on an infant.
    Koepp P; Rybak C; Rüdiger HW; Wendel U
    Z Kinderheilkd; 1974 Feb; 116(3):177-84. PubMed ID: 4813457
    [No Abstract]   [Full Text] [Related]  

  • 31. [Maple syrup urine disease with an intermittent relatively benign course].
    Müller H; Bickel H; Feist D; Lutz P
    Dtsch Med Wochenschr; 1971 Oct; 96(40):1552-7. PubMed ID: 5093339
    [No Abstract]   [Full Text] [Related]  

  • 32. Maple syrup urine disease. Two cases in Israel.
    Chemke J; Levin S
    Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maple syrup urine disease in an infant with microgyria.
    Martin JK; Norman RM
    Dev Med Child Neurol; 1967 Apr; 9(2):152-9. PubMed ID: 6059316
    [No Abstract]   [Full Text] [Related]  

  • 34. Electroencephalograms in a case of maple syrup urine disease: their relation to serum levels of branched-chain amino acids.
    Iinuma K; Saito T; Wada Y; Onuma A; Takamatsu N
    Tohoku J Exp Med; 1976 Oct; 120(2):191-5. PubMed ID: 982436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On prolonged diet-therapy of an infant with urinary valine and leucine disorders associated with mental retardation (maple syrup urine disease)].
    Schmidt GW; Benecke G; Peiffer J
    Helv Paediatr Acta; 1965 Jun; 20(2):147-68. PubMed ID: 5834532
    [No Abstract]   [Full Text] [Related]  

  • 36. [Isolated isoleucine deficiency in diet therapy of a case of maple syrup urine disease].
    Sanjurjo P; Centeno C; Vallo A; Ojembarrena E; Rodríguez Soriano J
    An Esp Pediatr; 1983 Nov; 19(5):389-92. PubMed ID: 6660656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A; Narojek L; Sykut-Cegielska J
    Rocz Panstw Zakl Hig; 2007; 58(1):95-101. PubMed ID: 17711097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemical-genetic studies in maple syrup disease].
    Goedde HW; Blume KG
    Med Welt; 1968 Dec; 49():2699-703. PubMed ID: 5730703
    [No Abstract]   [Full Text] [Related]  

  • 39. [Maple Syrup Urine Disease in a newborn infant].
    Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
    Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intermittent branched chain ketonuria (variant of maple syrup urine disease).
    Irwin WC; Martel SB; Goluboff N
    Clin Biochem; 1971 Jun; 4(2):52-8. PubMed ID: 5128296
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.